FSSAI Product Approval

The first and most important judgement in this area is whether a product requires FSSAI approval at all, because the answer determines everything. Products that conform to an existing food standard, or whose ingredients are all within the permitted lists, generally do not need specific product approval — they can be made under the appropriate licence. But a product with no applicable standard, or one using an ingredient not covered by the permitted lists, or a genuinely novel food, typically cannot be launched without going through the approval process first. Getting this determination right is the pivot on which the whole matter turns.

The consequences of misjudging it are serious in both directions. Launching a product that needed approval without it is a real contravention that can see the product pulled and the business penalised; conversely, unnecessarily pursuing approval for a product that was actually permitted wastes months and money. This determination requires genuine familiarity with what the standards and permitted lists cover, and we bring that familiarity, so a product takes the correct route — approval where it is genuinely needed, and straight to market where it is not.

• Products within existing standards or permitted lists usually need no approval.
• Non-specified, novel foods or novel ingredients generally require approval.
• Misjudging the requirement is costly in both directions.

The main triggers for product approval are non-specified foods and novel foods and ingredients. A non-specified food is one for which no standard has been laid down — it does not fit an existing defined category — and so cannot be assumed safe and permitted; it needs its safety established through approval. A novel food or ingredient is one without a history of significant safe use as food in India, which likewise cannot simply be presumed safe. Both categories reflect the same underlying caution: something new to the food supply should be assessed before it is sold, not after.

We help identify which of these applies to a given product and pursue the appropriate approval route, tailoring the dossier to the specific basis on which approval is required. A non-specified food and a genuinely novel ingredient raise somewhat different questions, and framing the application to the right one is part of doing it well. For an innovator, understanding precisely why their product needs approval — and therefore what the FSSAI will want to see — is the starting point for a successful application, and we establish that clearly at the outset.

The substance of a product approval is the safety dossier — the body of evidence that persuades the FSSAI the product or ingredient is safe for its intended use. This typically includes the detailed composition and specification, the intended use and consumption levels, the manufacturing process, and the safety evidence: toxicological data where relevant, the history of safe use, the regulatory status and approvals in other credible jurisdictions, and any studies bearing on safety. The dossier has to make a coherent, evidence-based case that the product is safe as intended to be sold and consumed.

We assemble this dossier to answer the FSSAI’s scientific questions convincingly, marshalling the available evidence — including a product’s approvals and safe use abroad, which carry real weight — and identifying where the evidence needs strengthening before submission. A common failing is a dossier that asserts safety without adequately demonstrating it, which invites a spiral of queries. We build a dossier that stands up to scientific scrutiny, because the quality of the safety case is the single biggest determinant of whether, and how quickly, an approval is granted.

• Composition, intended use and consumption levels.
• Toxicological data, history of safe use, and international status.
• A coherent, evidence-based safety case, not mere assertion.

Product-approval applications are not decided administratively; they are evaluated scientifically by the FSSAI’s scientific panels and committees, which examine the safety evidence and form a view on whether the product should be approved. This is a genuine expert review, and the panels may raise questions, seek clarification, or ask for additional data before making a recommendation. The process is correspondingly less predictable and longer than a routine licensing step, because it depends on satisfying a scientific assessment rather than meeting a checklist.

We engage with this evaluation actively — presenting the dossier in the way the scientific reviewers need to see it, anticipating the questions a panel is likely to raise, and responding promptly and substantively to any queries or data requests. Much of the skill in securing a product approval lies in this engagement: a dossier that pre-empts the panel’s concerns and an applicant who answers them well move far faster than one that meets each question with a scramble. We manage this scientific dialogue so the evaluation proceeds towards approval rather than stalling in rounds of unresolved queries.

For many novel or non-specified products, a powerful part of the safety case is the product’s or ingredient’s status in other credible regulatory systems. An ingredient that is approved and widely used in the food supply of jurisdictions with rigorous food-safety regimes, or that carries a favourable safety assessment from a respected authority, brings substantial evidential weight to an Indian application. It does not automatically secure approval — the FSSAI reaches its own view — but it materially strengthens the case that the product is safe.

We use this international dimension effectively, marshalling the approvals, safe-use history and safety assessments from other jurisdictions to reinforce the dossier, while being clear that they support rather than replace the Indian evaluation. For an importer bringing an internationally established but Indian-unapproved product to market, this is often the backbone of the safety case. We frame that international evidence in the way the FSSAI’s reviewers find persuasive, so a product’s established acceptance elsewhere works as hard as it can for its Indian approval.

A product approval is not the end of the compliance journey but the step that unlocks the rest of it. Once the FSSAI has approved a non-specified or novel product, the business can proceed to make and sell it under the appropriate licence, with labelling and any conditions the approval carries. The approval clears the fundamental question — may this product be sold at all — and the ordinary food-compliance requirements then apply to how it is licensed, labelled and marketed, which for a now-approved product is familiar territory.

We connect the product approval to that downstream compliance, so an approved product moves smoothly into licensed manufacture and compliant sale rather than clearing the scientific hurdle only to stumble on a licensing or labelling one. Handling the approval as part of the whole compliance picture — the licence, the labelling, any nutraceutical dimension — means the innovative product reaches the market as a coherent, fully compliant launch. We see it through from the determination that approval is needed to the product actually and lawfully on sale.